Host Resistance and Immune Aging

Clinics in Geriatric Medicine

Volumn 32, Issue 3, 2016, Pages 415-432

  Bandaranayake, Thilinie ^a   Shaw, Albert C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; B cell; Immunosenescence; Inflammation; Innate immunity; T cell

Indexed keywords

INFLUENZA VACCINE; RAPAMYCIN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AGE; AGING; ANTIBODY RESPONSE; B LYMPHOCYTE; BRAIN ISCHEMIA; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DRUG EFFECT; EXTRACELLULAR TRAP; HEART FAILURE; HOST RESISTANCE; HUMAN; IMMUNE DYSREGULATION; INFECTION CONTROL; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; REVIEW; T LYMPHOCYTE; CELLULAR IMMUNITY; IMMUNOLOGY;

AGING; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE;

EID: 84969706251     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2016.02.007     Document Type: Review

References (128)

1. 1 Yoshikawa, T.T., Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 30 (2000), 931–933.
2. 2 Vaz Fragoso, C.A., Gill, T.M., Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol A Biol Sci Med Sci 67 (2012), 264–275.
3. 3 Fulop, T., Le Page, A., Fortin, C., et al. Cellular signaling in the aging immune system. Curr Opin Immunol 29 (2014), 105–111.
4. 4 Shaw, A.C., Goldstein, D.R., Montgomery, R.R., Age-dependent dysregulation of innate immunity. Nat Rev Immunol 13 (2013), 875–887.
5. 5 Bruunsgaard, H., Andersen-Ranberg, K., Jeune, B., et al. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54 (1999), M357–M364.
6. 6 Fagiolo, U., Cossarizza, A., Scala, E., et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23 (1993), 2375–2378.
7. 7 Mari, D., Mannucci, P.M., Coppola, R., et al. Hypercoagulability in centenarians: the paradox of successful aging. Blood 85 (1995), 3144–3149.
8. 8 Paolisso, G., Rizzo, M.R., Mazziotti, G., et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 275 (1998), E294–E299.
9. 9 Stowe, R.P., Peek, M.K., Cutchin, M.P., et al. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 65 (2010), 429–433.
10. 10 Wei, J., Xu, H., Davies, J.L., et al. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51 (1992), 1953–1956.
11. 11 Bruunsgaard, H., Andersen-Ranberg, K., Hjelmborg, J., et al. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115 (2003), 278–283.
12. 12 Harris, T.B., Ferrucci, L., Tracy, R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999), 506–512.
13. 13 Reuben, D.B., Cheh, A.I., Harris, T.B., et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50 (2002), 638–644.
14. 14 Morrisette-Thomas, V., Cohen, A.A., Fulop, T., et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev 139 (2014), 49–57.
15. 15 Franceschi, C., Bonafe, M., Valensin, S., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908 (2000), 244–254.
16. 16 Salvioli, S., Monti, D., Lanzarini, C., et al. Immune system, cell senescence, aging and longevity–inflamm-aging reappraised. Curr Pharm Des 19 (2013), 1675–1679.
17. 17 Niwa, Y., Kasama, T., Miyachi, Y., et al. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci 44 (1989), 1655–1664.
18. 18 Sapey, E., Greenwood, H., Walton, G., et al. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood 123 (2014), 239–248.
19. 19 Wenisch, C., Patruta, S., Daxbock, F., et al. Effect of age on human neutrophil function. J Leukoc Biol 67 (2000), 40–45.
20. 20 Butcher, S.K., Chahal, H., Nayak, L., et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 70 (2001), 881–886.
21. 21 Simell, B., Vuorela, A., Ekstrom, N., et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of streptococcus pneumoniae by neutrophil phagocytosis. Vaccine 29 (2011), 1929–1934.
22. 22 Hazeldine, J., Harris, P., Chapple, I.L., et al. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell 13 (2014), 690–698.
23. 23 Fortin, C.F., Larbi, A., Dupuis, G., et al. GM-CSF activates the JAK/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogerontology 8 (2007), 173–187.
24. 24 Fortin, C.F., Larbi, A., Lesur, O., et al. Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J Leukoc Biol 79 (2006), 1061–1072.
25. 25 Qian, F., Guo, X., Wang, X., et al. Reduced bioenergetics and Toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging (Albany NY) 6 (2014), 131–139.
26. 26 Nomellini, V., Brubaker, A.L., Mahbub, S., et al. Dysregulation of neutrophil CXCR2 and pulmonary endothelial ICAM-1 promotes age-related pulmonary inflammation. Aging Dis 3 (2012), 234–247.
27. 27 Wong, K.L., Yeap, W.H., Tai, J.J., et al. The three human monocyte subsets: implications for health and disease. Immunol Res 53 (2012), 41–57.
28. 28 Nyugen, J., Agrawal, S., Gollapudi, S., et al. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 30 (2010), 806–813.
29. 29 van Duin, D., Mohanty, S., Thomas, V., et al. Age-associated defect in human TLR-1/2 function. J Immunol 178 (2007), 970–975.
30. 30 van Duin, D., Allore, H.G., Mohanty, S., et al. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 195 (2007), 1590–1597.
31. 31 Qian, F., Wang, X., Zhang, L., et al. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 11 (2012), 104–110.
32. 32 Lim, J.S., Nguyen, K.C., Nguyen, C.T., et al. Flagellin-dependent TLR5/Caveolin-1 as a promising immune activator in immunosenescence. Aging Cell 14 (2015), 907–915.
33. 33 Hearps, A.C., Martin, G.E., Angelovich, T.A., et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11 (2012), 867–875.
34. 34 Merino, A., Buendia, P., Martin-Malo, A., et al. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol 186 (2011), 1809–1815.
35. 35 Seidler, S., Zimmermann, H.W., Bartneck, M., et al. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol, 11, 2010, 30.
36. 36 Mohanty, S., Joshi, S.R., Ueda, I., et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis 211 (2015), 1174–1184.
37. 37 Markofski, M.M., Flynn, M.G., Carrillo, A.E., et al. Resistance exercise training-induced decrease in circulating inflammatory CD14+CD16+ monocyte percentage without weight loss in older adults. Eur J Appl Physiol 114 (2014), 1737–1748.
38. 38 Timmerman, K.L., Flynn, M.G., Coen, P.M., et al. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?. J Leukoc Biol 84 (2008), 1271–1278.
39. 39 Panda, A., Qian, F., Mohanty, S., et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 184 (2010), 2518–2527.
40. 40 Prakash, S., Agrawal, S., Cao, J.N., et al. Impaired secretion of interferons by dendritic cells from aged subjects to influenza: role of histone modifications. Age (Dordr) 35 (2013), 1785–1797.
41. 41 Qian, F., Wang, X., Zhang, L., et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 203 (2011), 1415–1424.
42. 42 Cao, J.N., Agrawal, A., Sharman, E., et al. Alterations in gene array patterns in dendritic cells from aged humans. PLoS One, 9, 2014, e106471.
43. 43 Agrawal, A., Agrawal, S., Cao, J.N., et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178 (2007), 6912–6922.
44. 44 Agrawal, A., Tay, J., Ton, S., et al. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J Immunol 182 (2009), 1138–1145.
45. 45 Prakash, S., Agrawal, S., Vahed, H., et al. Dendritic cells from aged subjects contribute to chronic airway inflammation by activating bronchial epithelial cells under steady state. Mucosal Immunol 7 (2014), 1386–1394.
46. 46 Spits, H., Artis, D., Colonna, M., et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 13 (2013), 145–149.
47. 47 Campos, C., Pera, A., Lopez-Fernandez, I., et al. Proinflammatory status influences NK cells subsets in the elderly. Immunol Lett 162 (2014), 298–302.
48. 48 Campos, C., Pera, A., Sanchez-Correa, B., et al. Effect of age and CMV on NK cell subpopulations. Exp Gerontol 54 (2014), 130–137.
49. 49 Borrego, F., Alonso, M.C., Galiani, M.D., et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 34 (1999), 253–265.
50. 50 Chidrawar, S.M., Khan, N., Chan, Y.L., et al. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing, 3, 2006, 10.
51. 51 Hayhoe, R.P., Henson, S.M., Akbar, A.N., et al. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol 71 (2010), 676–681.
52. 52 Le Garff-Tavernier, M., Beziat, V., Decocq, J., et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9 (2010), 527–535.
53. 53 Solana, R., Campos, C., Pera, A., et al. Shaping of NK cell subsets by aging. Curr Opin Immunol 29 (2014), 56–61.
54. 54 Solana, R., Tarazona, R., Gayoso, I., et al. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 24 (2012), 331–341.
55. 55 Hazeldine, J., Hampson, P., Lord, J.M., Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 11 (2012), 751–759.
56. 56 Ogata, K., An, E., Shioi, Y., et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 124 (2001), 392–397.
57. 57 Abu-Taha, M., Rius, C., Hermenegildo, C., et al. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J Immunol 183 (2009), 1393–1402.
58. 58 Maggio, M., Basaria, S., Ble, A., et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 91 (2006), 345–347.
59. 59 Hazeldine, J., Arlt, W., Lord, J.M., Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol 120:2–3 (2010), 127–136.
60. 60 Pilling, L.C., Joehanes, R., Melzer, D., et al. Gene expression markers of age-related inflammation in two human cohorts. Exp Gerontol 70 (2015), 37–45.
61. 61 Lumeng, C.N., Liu, J., Geletka, L., et al. Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol 187 (2011), 6208–6216.
62. 62 Xu, M., Tchkonia, T., Ding, H., et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci U S A 112 (2015), E6301–E6310.
63. 63 Tchkonia, T., Zhu, Y., van Deursen, J., et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123 (2013), 966–972.
64. 64 Johnson, S.C., Rabinovitch, P.S., Kaeberlein, M., mTOR is a key modulator of ageing and age-related disease. Nature 493 (2013), 338–345.
65. 65 Herranz, N., Gallage, S., Mellone, M., et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol 17 (2015), 1205–1217.
66. 66 Laberge, R.M., Sun, Y., Orjalo, A.V., et al. mTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1a translation. Nat Cell Biol 17 (2015), 1049–1061.
67. 67 Flynn, J.M., O'Leary, M.N., Zambataro, C.A., et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 12 (2013), 851–862.
68. 68 Harrison, D.E., Strong, R., Sharp, Z.D., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460 (2009), 392–395.
69. 69 Xie, L., Sun, F., Wang, J., et al. mTOr signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. J Immunol 192 (2014), 6009–6019.
70. 70 Mannick, J.B., Del Giudice, G., Lattanzi, M., et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med, 6, 2014, 268ra179.
71. 71 Jylhava, J., Jylha, M., Lehtimaki, T., et al. Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the vitality 90+ study. Exp Gerontol 47 (2012), 372–378.
72. 72 Jylhava, J., Kotipelto, T., Raitala, A., et al. Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the vitality 90+ study. Mech Ageing Dev 132 (2011), 20–26.
73. 73 Jylhava, J., Nevalainen, T., Marttila, S., et al. Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Aging Cell 12 (2013), 388–397.
74. 74 Itagaki, K., Kaczmarek, E., Lee, Y.T., et al. Mitochondrial DNA released by trauma induces neutrophil extracellular traps. PLoS One, 10, 2015, e0120549.
75. 75 Pinti, M., Cevenini, E., Nasi, M., et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for “inflamm-aging”. Eur J Immunol 44 (2014), 1552–1562.
76. 76 Fernandez-Ruiz, I., Arnalich, F., Cubillos-Zapata, C., et al. Mitochondrial DAMPS induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction. PLoS One, 9, 2014, e95073.
77. 77 Shimada, K., Crother, T.R., Karlin, J., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36 (2012), 401–414.
78. 78 Elliott, E.I., Sutterwala, F.S., Initiation and perpetuation of nlrp3 inflammasome activation and assembly. Immunol Rev 265 (2015), 35–52.
79. 79 Imaeda, A.B., Watanabe, A., Sohail, M.A., et al. Acetaminophen-induced hepatotoxicity in mice is dependent on TLR9 and the NALP3 inflammasome. J Clin Invest 119 (2009), 305–314.
80. 80 Iyer, S.S., Pulskens, W.P., Sadler, J.J., et al. Necrotic cells trigger a sterile inflammatory response through the NLRP3 inflammasome. Proc Natl Acad Sci U S A 106 (2009), 20388–20393.
81. 81 Li, H., Ambade, A., Re, F., Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol 183 (2009), 1528–1532.
82. 82 Youm, Y.H., Grant, R.W., McCabe, L.R., et al. Canonical NLRP3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 18 (2013), 519–532.
83. 83 Baroja-Mazo, A., Martin-Sanchez, F., Gomez, A.I., et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 15 (2014), 738–748.
84. 84 Franklin, B.S., Bossaller, L., De Nardo, D., et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol 15 (2014), 727–737.
85. 85 Palmer, D.B., The effect of age on thymic function. Front Immunol, 4, 2013, 316.
86. 86 den Braber, I., Mugwagwa, T., Vrisekoop, N., et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 36 (2012), 288–297.
87. 87 Sauce, D., Larsen, M., Fastenackels, S., et al. Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest 119 (2009), 3070–3078.
88. 88 Chidrawar, S., Khan, N., Wei, W., et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 155 (2009), 423–432.
89. 89 Litjens, N.H., de Wit, E.A., Betjes, M.G., Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing, 8, 2011, 2.
90. 90 Looney, R.J., Falsey, A., Campbell, D., et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 90 (1999), 213–219.
91. 91 Ouyang, Q., Wagner, W.M., Voehringer, D., et al. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor g1 (KLRG1). Exp Gerontol 38 (2003), 911–920.
92. 92 Wikby, A., Johansson, B., Olsson, J., et al. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37 (2002), 445–453.
93. 93 Limaye, A.P., Kirby, K.A., Rubenfeld, G.D., et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300 (2008), 413–422.
94. 94 Wertheimer, A.M., Bennett, M.S., Park, B., et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 192 (2014), 2143–2155.
95. 95 Hadrup, S.R., Strindhall, J., Kollgaard, T., et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 176 (2006), 2645–2653.
96. 96 Khan, N., Shariff, N., Cobbold, M., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169 (2002), 1984–1992.
97. 97 Ouyang, Q., Wagner, W.M., Wikby, A., et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 23 (2003), 247–257.
98. 98 Ouyang, Q., Wagner, W.M., Zheng, W., et al. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 39 (2004), 607–613.
99. 99 Vescovini, R., Biasini, C., Telera, A.R., et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 184 (2010), 3242–3249.
100. 100 Britanova, O.V., Putintseva, E.V., Shugay, M., et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol 192 (2014), 2689–2698.
101. 101 Qi, Q., Liu, Y., Cheng, Y., et al. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A 111 (2014), 13139–13144.
102. 102 Laydon, D.J., Bangham, C.R., Asquith, B., Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach. Phil Trans R Soc B, 370, 2015, 20140291.
103. 103 Weng, N.P., Akbar, A.N., Goronzy, J., CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30 (2009), 306–312.
104. 104 Topp, M.S., Riddell, S.R., Akatsuka, Y., et al. Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J Exp Med 198 (2003), 947–955.
105. 105 Chou, J.P., Effros, R.B., T cell replicative senescence in human aging. Curr Pharm Des 19 (2013), 1680–1698.
106. 106 Dolfi, D.V., Mansfield, K.D., Polley, A.M., et al. Increased T-Bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans. J Leukoc Biol 93 (2013), 825–836.
107. 107 Henson, S.M., Akbar, A.N., KLRG1–more than a marker for T cell senescence. Age (Dordr) 31 (2009), 285–291.
108. 108 Li, G., Yu, M., Lee, W.W., et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 18 (2012), 1518–1524.
109. 109 Yu, M., Li, G., Lee, W.W., et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A 109 (2012), E879–E888.
110. 110 Henson, S.M., Lanna, A., Riddell, N.E., et al. P38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J Clin Invest 124 (2014), 4004–4016.
111. 111 Lanna, A., Henson, S.M., Escors, D., et al. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol 15 (2014), 965–972.
112. 112 Gibson, K.L., Wu, Y.C., Barnett, Y., et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8 (2009), 18–25.
113. 113 Wang, C., Liu, Y., Xu, L.T., et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 192 (2014), 603–611.
114. 114 Kolar, G.R., Mehta, D., Wilson, P.C., et al. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol 64 (2006), 314–324.
115. 115 Martin, V., Bryan Wu, Y.C., Kipling, D., et al. Ageing of the B-cell repertoire. Phil Trans R Soc B, 370, 2015, 20140237.
116. 116 Sasaki, S., Sullivan, M., Narvaez, C.F., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 121 (2011), 3109–3119.
117. 117 Frasca, D., Diaz, A., Romero, M., et al. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 28 (2010), 8077–8084.
118. 118 Frasca, D., Landin, A.M., Lechner, S.C., et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180 (2008), 5283–5290.
119. 119 Frasca, D., Diaz, A., Romero, M., et al. MicroRNAs miR-155 and miR-16 decrease AID and E47 in B cells from elderly individuals. J Immunol 195 (2015), 2134–2140.
120. 120 Frasca, D., Diaz, A., Romero, M., et al. High TNF-alpha levels in resting B cells negatively correlate with their response. Exp Gerontol 54 (2014), 116–122.
121. 121 Frasca, D., Diaz, A., Romero, M., et al. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 33 (2015), 1433–1439.
122. 122 Metcalf, T.U., Cubas, R.A., Ghneim, K., et al. Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell 14 (2015), 421–432.
123. 123 Thakar, J., Mohanty, S., West, A.P., et al. Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging (Albany NY) 7 (2015), 38–52.
124. 124 Furman, D., Jojic, V., Kidd, B., et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol, 9, 2013, 659.
125. 125 Vanzant, E.L., Hilton, R.E., Lopez, C.M., et al. Advanced age is associated with worsened outcomes and a unique genomic response in severely injured patients with hemorrhagic shock. Crit Care, 19, 2015, 77.
126. 126 Jung, M., Pfeifer, G.P., Aging and DNA methylation. BMC Biol, 13, 2015, 7.
127. 127 Marioni, R.E., Shah, S., McRae, A.F., et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol, 16, 2015, 25.
128. 128 Zapata, H.J., Quagliarello, V.J., The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 63 (2015), 776–781.